The present invention is directed to non-naturally occurring peptides containing a
membrane-penetrating amino acid sequence and further at least one polycationic moiety or …

0005 2. Background Art 0006 T lymphocytes are both key effector cells and key regulatory
cells of the immune System. The ability to Stimu late or inhibit specific T cell responses is a …

US10688194B2 - Cell penetrating peptides for intracellular delivery of molecules - Google
Patents US10688194B2 - Cell penetrating peptides for intracellular delivery of molecules …

The present invention provides recombinant viral particles for gene therapy and liposome
compositions for drug deliv ery comprising an env protein of MMTV. The invention also …

A complex that comprises (i) a nucleic acid,(ii) an integrin-binding component, for example,
an integrin-binding peptide,(iii) a polycationic nucleic acid-binding component, for example …

This disclosure relates to compositions for delivering agents to a subject, and in particular, to
compositions for delivery of therapeutic agents or diagnostic agents in the presence or …

The present invention relates to a novel delivery system for delivering therapeutic agents
into living cells, and more par ticularly, to novel chemical moieties that are designed capable …

The present invention relates to a novel delivery system for delivering therapeutic agents
into living cells, and more par ticularly, to novel chemical moieties that are designed capable …

5,034,506 A 7, 1991 Summerton et al. 5,418, 139 A 5/1995 Campbell 5,541.308 A 7/1996
Hogan et al. 5,593.974 A 1/1997 Rosenberg et al. 5,608,046 A 3, 1997 Cook et al …

0003. The selective delivery of therapeutic agents to diseased tissue, in Vivo, remains a
major challenge in the interests of improved therapeutic outcomes. It must be appreciated …